Furthermore, as described in detail previously [18], CXCR2 positive ovarian cancer cells enhanced more the promoter activity and mRNA levels of CXCL1 and 2 by NF-κB potentiation through EGFR-activated Akt compared to CXCR2 negative cells. The gene discussed is NFKB1; the disease is ovarian cancer.